Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Groeneveld CS, Fontugne J, Cabel L, Bernard-Pierrot I, et al. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy. Eur J Cancer 2021;148:181-189.
PMID: 33743486


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016